Literature DB >> 30349844

Sequential Gastroenteritis Outbreaks in a Single Year Caused by Norovirus Genotypes GII.2 and GII.6 in an Institutional Setting.

Consolee K Karangwa1, Gabriel I Parra2, Karin Bok3, Jordan A Johnson1, Eric A Levenson1, Kim Y Green1.   

Abstract

BACKGROUND: Norovirus is a leading cause of acute gastroenteritis worldwide. Improved diagnostic capability has been instrumental in the characterization of archival norovirus strains associated with gastroenteritis outbreaks that were investigated decades ago. One such investigation was that of 2 sequential gastroenteritis outbreaks that occurred in 1971 at the former Henryton State Hospital in Maryland. Approximately 40% of the resident population experienced clinical symptoms in both outbreaks, which occurred 11 months apart.
METHODS: Stored stools and paired sera were re-analyzed to investigate the etiology of the 2 outbreaks.
RESULTS: Different norovirus genotypes were identified as the etiological agents responsible for the illnesses, with GII.2 associated with the first outbreak and GII.6 with the second. The viruses were antigenically distinct as determined by analyses of hyperimmune sera raised against the corresponding virus-like particles in animals, as well as paired sera from infected individuals.
CONCLUSIONS: The observed antigenic differences were consistent with the failure of the GII.2 strain to provide cross-protective immunity to the GII.6 strain a few months later. An understanding of antigenic diversity among norovirus genotypes will be important in the design of norovirus vaccines.

Entities:  

Keywords:  calicivirus; gastroenteritis; norovirus; outbreak; reinfection

Year:  2017        PMID: 30349844      PMCID: PMC5903414          DOI: 10.1093/ofid/ofx236

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   3.835


  40 in total

Review 1.  Norovirus gene expression and replication.

Authors:  Lucy G Thorne; Ian G Goodfellow
Journal:  J Gen Virol       Date:  2013-11-16       Impact factor: 3.891

2.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.

Authors:  P C Johnson; J J Mathewson; H L DuPont; H B Greenberg
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

Review 3.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

4.  Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.

Authors:  Jennifer L Cannon; Lisa C Lindesmith; Eric F Donaldson; Lauryn Saxe; Ralph S Baric; Jan Vinjé
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

5.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

6.  Clinical immunity in acute gastroenteritis caused by Norwalk agent.

Authors:  T A Parrino; D S Schreiber; J S Trier; A Z Kapikian; N R Blacklow
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

7.  Disease course and viral shedding in experimental Norwalk virus and Snow Mountain virus infection.

Authors:  A E Kirby; J Shi; J Montes; M Lichtenstein; C L Moe
Journal:  J Med Virol       Date:  2014-02-14       Impact factor: 2.327

8.  Sequential gastroenteritis episodes caused by 2 norovirus genotypes.

Authors:  Gabriel I Parra; Kim Y Green
Journal:  Emerg Infect Dis       Date:  2014-06       Impact factor: 6.883

9.  Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity.

Authors:  Gabriel I Parra; R Burke Squires; Consolee K Karangwa; Jordan A Johnson; Cara J Lepore; Stanislav V Sosnovtsev; Kim Y Green
Journal:  PLoS Pathog       Date:  2017-01-19       Impact factor: 6.823

10.  Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals.

Authors:  Severine Marionneau; Nathalie Ruvoën; Beatrice Le Moullac-Vaidye; Monique Clement; Anne Cailleau-Thomas; Guillermo Ruiz-Palacois; Pengwei Huang; Xi Jiang; Jacques Le Pendu
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

View more
  6 in total

1.  Associations of infection control measures and norovirus outbreak outcomes in healthcare settings: a systematic review and meta-analysis.

Authors:  Carly Adams; Shenita R Peterson; Aron J Hall; Umesh Parashar; Benjamin A Lopman
Journal:  Expert Rev Anti Infect Ther       Date:  2021-08-04       Impact factor: 5.091

Review 2.  Norovirus Attachment and Entry.

Authors:  Vincent R Graziano; Jin Wei; Craig B Wilen
Journal:  Viruses       Date:  2019-05-30       Impact factor: 5.048

3.  Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses.

Authors:  Joseph A Kendra; Kentaro Tohma; Lauren A Ford-Siltz; Cara J Lepore; Gabriel I Parra
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

Review 4.  Understanding the relationship between norovirus diversity and immunity.

Authors:  Lauren A Ford-Siltz; Kentaro Tohma; Gabriel I Parra
Journal:  Gut Microbes       Date:  2021 Jan-Dec

5.  Virus-Host Interactions Between Nonsecretors and Human Norovirus.

Authors:  Lisa C Lindesmith; Paul D Brewer-Jensen; Michael L Mallory; Kara Jensen; Boyd L Yount; Veronica Costantini; Matthew H Collins; Caitlin E Edwards; Timothy P Sheahan; Jan Vinjé; Ralph S Baric
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-04-11

6.  The effect of proteolytic enzymes and pH on GII.4 norovirus, during both interactions and non-interaction with Histo-Blood Group Antigens.

Authors:  Manon Chassaing; Maëlle Robin; Julie Loutreul; Didier Majou; Gaël Belliot; Alexis de Rougemont; Nicolas Boudaud; Christophe Gantzer
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.